Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Strong track record of returning value to shareholders in the form of dividends. The stock appears to be fairly valued according to the Gordon Growth Model with moderate upside potential.

We Like Walgreens Boots Alliance's Dividends

Walgreens is transforming itself by leveraging its vast store footprint into primary care destinations. Its digital sales are growing impressively and management is focused on achieving billions in annual cost savings.

Walgreens Is Cheap At 8.7x P/E And 5% Yield

Walgreens Boots Alliance has seen its results gradually slide over the past decade. The Boots acquisition missed the mark, and the firm's core business strategy needs some changes.

Walgreens Boots Alliance: A Value Buy Despite Obvious Headwinds

DEERFIELD, Ill.--( BUSINESS WIRE )--Walgreens today announced that rapid flu testing will now be available at more than 5,000 pharmacies nationwide to help communities identify and manage the highly transmissible viruses circulating this holiday season.* Walgreens will use Abbott's ID NOW™ devices to administer the tests, and results will be available within two hours.

Walgreens Now Offering Flu and COVID-19 Testing in a Single Visit at Over 5,000 Locations

DEERFIELD, Ill.--( BUSINESS WIRE )--As communities nationwide head into the homestretch of the holiday season, Walgreens is here to help to relieve last-minute stress with convenient shopping solutions. With stores open on Christmas Eve and Christmas Day, Walgreens offers customers fast and simple solutions for getting retail products in-store, as well as 1-hour Delivery, 24-hour Delivery, 30-minute Pickup, and gift suggestions for everyone on your list.

Walgreens Delivers Customers the Gift of Last-Minute Convenience this Holiday

The stock was recently trading around its 10-year low.

Is Walgreens a Buy?

Archer-Daniels-Midland Company

Campbell Soup

Estee Lauder

Constellation Brands

With the central bank looking unlikely to pivot anytime soon, fears are mounting on Wall Street that a recession could be in the cards for next year.

Jim Cramer says he likes these 5 consumer staple stocks in 2023

Franklin Resources

Leggett & Platt

V.F.

"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger Investing. 65 Aristocrats screened as of December 12, 2022 represented all eleven Morningstar Sectors. Broker estimated-top-ten net-gains ranged 10.63%-21.12% topped by VFC & TGT.

4 Dividend Aristocrat Buys For December

Intel

AT&T

These time-tested companies, with yields ranging from 4.8% to 5.8%, are plain-as-day bargains for opportunistic investors.

3 High-Yield S&P 500 Dividend Stocks Begging to Be Bought for 2023

Aflac

Flowers Foods

Fiverr

Eli Lilly

PayPal

Verizon

Before we discuss the top 10 stock picks for 2023, we can all agree that the economy has two pathways from here. One, the real impact of the rate hikes sits in front of us and will trigger a deep recession in 2023.

Our Top 10 Stock Picks for 2023

AbbVie

Citigroup

Cisco Systems

It is almost hard to believe that at this time last year interest rates were still near zero.

Rates Head Higher Again This Week: 5 Value Stocks to Buy Now That Come With Big Dividends

DEERFIELD, Ill.--( BUSINESS WIRE )--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) will release its fiscal 2023 first quarter results at 7 a.m. ET Thursday, Jan. 5, 2023, followed by a one-hour conference call with WBA management beginning at 8:30 a.m. ET.

Walgreens Boots Alliance Schedules Fiscal 2023 First Quarter Earnings Announcement for January 5, 2023

Caterpillar

Home Depot

While the Dow has recovered some from its recent lows, there are several Dow stocks that are no-brainer buys right now.

Dow Jones Bear Market: 3 No-Brainer Stocks for Market Growth

AmerisourceBergen

Walgreens Boots Alliance has sold some AmerisourceBergen Corp's shares for proceeds of $1 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor, by 3% to about 17%.

Walgreens cuts stake in AmerisourceBergen through $1 bln share sale

DEERFIELD, Ill.--( BUSINESS WIRE )--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of AmerisourceBergen Corporation (NYSE: ABC) common stock pursuant to Rule 144 for proceeds of approximately $0.8 billion and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by AmerisourceBergen for proceeds of approximately $0.2 billion.

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $1.0 billion of Proceeds

CVS Health

The Peter Lynch approach is not particularly well-known among dividend investors, primarily because the man is so famous for picking 10 baggers and is typically regarded as a growth rather than an income investor. However, throughout his career and writings, he's provided enough wisdom into the choice of dividend stocks too.

Walgreens Vs. CVS: Peter Lynch Shows The Better 2023 Dividend Stock

DoorDash

DEERFIELD, Ill.--( BUSINESS WIRE )--Today, in partnership with DoorDash and Uber, Walgreens announced free delivery of Paxlovid, a COVID-19 oral antiviral therapy, directly to the doorsteps of those who need it.

Walgreens Launches Free Paxlovid Delivery Services with DoorDash and Uber

DEERFIELD, Ill.--( BUSINESS WIRE )--Walgreens announced today that it will hold its annual Localization Summit, a virtual showcase for diverse, local and regional businesses and entrepreneurs to share their retail offerings with the merchants of the national drugstore chain. The virtual event, hosted by RangeMe and ECRM, provides local suppliers the opportunity to connect with the Walgreens Merchandising team, share their products and receive feedback with the ultimate goal of being stocked on Walgreens shelves in their local areas.

Walgreens Invites Diverse, Local and Regional Vendors Nationwide to Participate in a Localization Summit

Baidu

The predominantly growth-driven Nasdaq 100 is home to three amazing deals hiding in plain sight.

3 Nasdaq 100 Stocks That Are Surefire End-of-Year Buys

Realty Income Corp

Dividend stocks have long offered returns competitive with fixed-income investments.

Want $1,000 in Passive Income? 3 High-Dividend Stocks to Snap Up

Target

Short-term challenges for these two strong businesses are providing attractive buying opportunities.

2 Beaten-Down Dividend Aristocrats That Are No-Brainer Buys for 2023

When you need baby formula at 3 a.m., options are limited.

Walgreens Pushes Limits and Peers With 24/7 Delivery

In the e-commerce era, customers expect to be able to order and receive anything, anywhere at any time. Most retailers have solved the first two pieces of the equation, with massive online catalogs and omnichannel fulfillment services that allow customers to pick up or receive orders at home, in store or at the curb.

Walgreens launches 24/7 same-day delivery at nearly 400 stores

Is the company's expansion into healthcare a good reason to buy the stock?

Why Healthcare Could Be a Make-or-Break Strategy for Walgreens

Although Walgreens is trading at a comparatively lower valuation of 0.3x, trailing revenues than 0.

News for Walgreens Stock (WBA)